The Monitoring of Drug Safety: Can Risk-Benefit Models Detect Those Signals with High Impact?

T.P. van Staa; F. de Vries; J. Parkinson; H.G.M. Leufkens

The Monitoring of Drug Safety: Can Risk-Benefit Models Detect Those Signals with High Impact?

T.P. van Staa, F. de Vries, J. Parkinson, H.G.M. Leufkens

Dept of Pharmaceutical Sciences

extern

Research output: Contribution to conference › Abstract › Other research output

Original language	Undefined/Unknown
Pages	S74
Number of pages	1
Publication status	Published - 19 Aug 2007
Event	23rd International Conference on Pharmacoepidemiology & Therapeutic Risk Management - Duration: 19 Aug 2007 → 22 Aug 2007

Conference

Conference	23rd International Conference on Pharmacoepidemiology & Therapeutic Risk Management
Period	19/08/07 → 22/08/07

Bibliographical note

23rd International Conference on Pharmacoepidemiology & Therapeutic Risk Management

Keywords

Farmacie/Biofarmaceutische wetenschappen (FARM)
Epidemiology
Farmacie(FARM)
Biomedische technologie en medicijnen
Ziekenhuisstructuur en organisatie van de gezondheidszorg
Public Health

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Cite this

@conference{c4c42175876d4818b92e7f189f350869,

title = "The Monitoring of Drug Safety: Can Risk-Benefit Models Detect Those Signals with High Impact?",

keywords = "Farmacie/Biofarmaceutische wetenschappen (FARM), Epidemiology, Farmacie(FARM), Biomedische technologie en medicijnen, Ziekenhuisstructuur en organisatie van de gezondheidszorg, Public Health",

author = "{van Staa}, T.P. and {de Vries}, F. and J. Parkinson and H.G.M. Leufkens",

note = "23rd International Conference on Pharmacoepidemiology & Therapeutic Risk Management; 23rd International Conference on Pharmacoepidemiology & Therapeutic Risk Management ; Conference date: 19-08-2007 Through 22-08-2007",

year = "2007",

month = aug,

day = "19",